Cleared Traditional

K032519 - ENDO PAT 2000

K032519 is an FDA 510(k) clearance for ENDO PAT 2000, manufactured by Itamar Medical. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 89-day FDA review.

K032519 · Itamar Medical · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2003
Decision
89d
Days
Class 2
Risk

K032519 is an FDA 510(k) clearance for the ENDO PAT 2000. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Itamar Medical (Ra'Ananna 43373, IL). The FDA issued a Cleared decision on November 12, 2003 after a review of 89 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Itamar Medical devices

FDA 510(k) Submission Details - K032519

510(k) Number K032519 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 15, 2003
Decision Date November 12, 2003
Days to Decision 89 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
36d faster than avg
Panel avg: 125d · This submission: 89d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 284
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K032519.
HORIZON ANGIO CATHLAB
K043564 · Mennen Medical , Ltd. · Jan 2005
MODIFICATION TO: RADIANALYZER, MODEL 12711
K042628 · Radi Medical Systems AB · Jan 2005
SYNESCOPE, EASYSCOPE, SYNECOM, HOLTERREADER
K042002 · Ela Medical, Inc. · Oct 2004
T-WAVE ALTERNANS (TWA) ALGORITHM OPTION
K032513 · Ge Medical Systems Information Technologies · Oct 2003
MODIFICATION TO: MAC-LAB/CARDIOLAB EP/COMBOLAB SYSTEM
K032577 · Ge Medical Systems Information Technologies · Oct 2003
INFINITY MEGACARE
K031970 · Siemens Medical Solutions USA, Inc. · Sep 2003